Basic science and translational implications of current knowledge on neuroendocrine tumors
Journal of Clinical Investigation · 03.03.2025 · 135 (5)
DOI: 10.1172/jci186702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.03.2025. Verfasst von Lynnette Fernandez-Cuesta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Computational Cancer Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Tumor Microenvironment, Translational Research, Biomedical, Translational Science, Biomedical. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Neuroendocrine tumors (NETs) are a diverse group of malignancies that can occur in various organs, with a notable prevalence in the lungs and gastrointestinal tract, which are the focus of this Review. Although NETs are rare in individual organs, their incidence has increased over recent decades, highlighting the urgent need for current classification systems to evolve by incorporating recent advances in the understanding of NET biology. Several omics studies have revealed molecular subtypes, which, when integrated into existing classification frameworks, may provide more clinically relevant insights for patients with NETs. This Review examines recent progress in elucidating the biology of NETs, with a particular emphasis on the tumor microenvironment and cells of origin. The existence of different cells of origin, which may contribute to distinct molecular groups, along with profiles of immune infiltration — despite being generally low — could explain the emergence of more aggressive cases and the potential for metastatic progression. Given the molecular heterogeneity of NETs and the diversity of their microenvironments and different cells of origin, there is an urgent need to develop morphomolecular classification systems. Such systems would make it possible to better characterize tumor progression, identify new therapeutic targets, and, ultimately, guide the development of personalized therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Computational Cancer Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- Department of Pulmonary Medicine, Erasmus MC Cancer institute, University Medical Center, Rotterdam, Netherlands.
- GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
- University of Bristol Medical School, Bristol, United Kingdom.
- European Molecular Biology Laboratory Barcelona, Tissue Biology and Disease Modeling, Barcelona, Spain.
- Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
Förderung
- World Health Organization
Zitieren
APA
Fernandez-Cuesta, L., Alcala, N., Mathian, E., Derks, J., Thirlwell, C., Dayton, T., Marinoni, I., Perren, A., Walter, T., & Foll, M. (2025). Basic science and translational implications of current knowledge on neuroendocrine tumors. Journal of Clinical Investigation, 135(5). https://doi.org/10.1172/jci186702
Vancouver
Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T, et al. Basic science and translational implications of current knowledge on neuroendocrine tumors. Journal of Clinical Investigation. 2025;135(5). doi:10.1172/jci186702
BibTeX
@article{FernandezCuesta2025,
author = {Fernandez-Cuesta, Lynnette and Alcala, Nicolas and Mathian, Emilie and Derks, Jules and Thirlwell, Chrissie and Dayton, Talya and Marinoni, Ilaria and Perren, Aurel and Walter, Thomas and Foll, Matthieu},
title = {Basic science and translational implications of current knowledge on neuroendocrine tumors},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {5},
doi = {10.1172/jci186702}
}
EUVIMED